TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

International Journal of Radiation Biology

Volumn 83, Issue 6, 2007, Pages 409-420

  Sims, A H ^a   Finnon, P ^b   Miller, C J ^a   Bouffler, S D ^b   Howell, A ^a   Scott, D ^a   Clarke, R B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Breast cancer; G2 assay; Lymphocytes; Microarray; NFKB1; Radiosensitivity; TPD52

Indexed keywords

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL VACUOLE; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILIAL CANCER; FEMALE; GENE EXPRESSION; GENETIC TRAIT; GENETIC TRANSCRIPTION; HERITABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; IRRADIATION; LYMPHOCYTE; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION RESPONSE; RADIOSENSITIVITY; T LYMPHOCYTE; TRANSCRIPTOMICS;

BREAST NEOPLASMS; CHROMOSOMES; FEMALE; G2 PHASE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B P50 SUBUNIT; RADIATION TOLERANCE; RISK ASSESSMENT; RISK FACTORS; STATISTICS; T-LYMPHOCYTES;

EID: 34248531601     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000701317366     Document Type: Article

References (49)

1. Ahn SH, Sawada H, Ro JY, Nicolson GL. 1997. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clinical and Experimental Metastasis 15:151-156.
2. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. 2004. Molecular characterization of the tumormicroenvironment in breast cancer. Cancer Cell 6:17-32.
3. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. 2001. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genetic Epidemiology 21:1-18.
4. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nature Cell Biology 9:201-209.
5. Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, Byrne JA. 2000. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes Chromosomes Cancer 29:48-57.
6. Borresen-Dale AL, Sharma P. 2005. Expression profiling of peripheral blood cells for early detection. Breast Cancer Research 7(Supp2):S8.
7. Boutros R, Byrne JA. 2005. D53 (TPD52L1) is a cell cycleregulated protein maximally expressed at the G2-M transition in breast cancer cells. Experimental Cell Research 310:152-165.
8. Breitling R, Armengaud P, Amtmann A, Herzyk P. 2004. Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Letters 573:83-92.
9. Bryant PE, Gray L, Riches AC, Steel CM, Finnon P, Howe O, Kesterton I, Vral A, Curwen GB, Smart V, Tawn EJ, Whitehouse CA. 2002. The G2 chromosomal radiosensitivity assay: A technical report. International Journal of Radiation Biology 78:863-866.
10. Burrill W, Levine EL, Hindocha P, Roberts SA, Scott D. 2000. The use of cryopreserved lymphocytes in assessing interindividual radiosensitivity with the micronucleus assay. International Journal of Radiation Biology 76:375-382.
11. Byrne JA, Tomasetto C, Garnier JM, Rouyer N, Mattei MG, Bellocq JP, Rio MC, Basset P. 1995. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Research 55:2896-2903.
12. Cao Q, Chen J, Zhu L, Liu Y, Zhou Z, Sha J, Wang S, Li J. 2006. A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins. Biochemical and Biophysical Research Communications 344:798-806.
13. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS. 2003. Natural variation in human gene expression assessed in lymphoblastoid cells. Nature Genetics 33:422-425.
14. Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. 2003. Transcription factors activated inmammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22:5813-5827.
15. Culhane AC, Thioulouse J, Perriere G, Higgins DG. 2005. MADE4: An R package for multivariate analysis of gene expression data. Bioinformatics 21:2789-2790.
16. Ding GR, Honda N, Nakahara T, Tian F, Yoshida M, Hirose H, Miyakoshi J. 2003. Radiosensitization by inhibition of IkappaB-alpha phosphorylation in human glioma cells. Radiation Research 160:232-237.
17. Houlston RS, Peto J. 2004. The search for low-penetrance cancer susceptibility alleles. Oncogene 23:6471-6476.
18. Howe OL, Daly PA, Seymour C, Ormiston W, Nolan C, Mothersill C. 2005. Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: A comparison with other studies. International Journal of Radiation Biology 81:373-378.
19. Howell A, Sims AH, Ong KR, Harvie M, Evans DG, Clarke RB. 2005. Mechanisms of disease: prediction and prevention of breast cancer - cellular and molecular interactions. Nature Clinical Practice Oncology 2:635-646.
20. Ihaka R, Gentleman R. 1996. R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 5:299-314.
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
22. Jung M, Zhang Y, Lee S, Dritschilo A. 1995. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 268:1619-1621.
23. Kontou M, Adelfalk C, Hirsch-Kauffmann M, Schweiger M. 2003. Suboptimal action of NF-kappaB in Fanconi anemia cells results from low levels of thioredoxin. Biological Chemistry 384:1501-1507.
24. Kote-Jarai Z, Matthews L, Osorio A, Shanley S, Giddings I, Moreews F, Locke I, Evans DG, Eccles D, Williams RD, Girolami M, Campbell C, Eeles R. 2006. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clinical Cancer Research 12:3896-3901.
25. Kote-Jarai Z, Williams RD, Cattini N, Copeland M, Giddings I, Wooster R, tePoele RH, Workman P, Gusterson B, Peacock J, Gui G, Campbell C, Eeles R. 2004. Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status. Clinical Cancer Research 10:958-963.
26. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. 2006. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041-1055.
27. Linard C, Marquette C, Mathieu J, Pennequin A, Clarencon D, Mathe D. 2004. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: Effect of an NF-kappaB inhibitor. International Journal of Radiation Oncology Biology Physics 58:427-434.
28. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC. 2004. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5:607-616.
29. Magne N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gerard JP, Peyron JF. 2006. NF-kappaB modulation and ionizing radiation: Mechanisms and future directions for cancer treatment. Cancer Letters 231:158-168.
30. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. 2005. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Research 65:11259-11264.
31. Mendonca MS, Hardacre M, Datzman N, Comerford K, Chin-Sinex H, Sweeny C. 2003. Inhibition of NFKappaB activity by the anti-inflammatory sesquiterpene, parthenolide slows cell growth and increases radiation sensitivity. International Journal of Radiation Oncology-Biology-Physics 57:S354.
32. Murphy KM, Reiner SL. 2002. The lineage decisions of helper T cells. National Review of Immunology 2:933-944.
33. O'Donovan MR, Freemantle MR, Hull G, Bell DA, Arlett CF, Cole J. 1995. Extended-term cultures of human T-lymphocytes: A practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis 10:189-201.
34. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. 2002. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genetics 31:33-36.
35. Pikarsky E, Ben-Neriah Y. 2006. NF-kappaB inhibition: A double-edged sword in cancer? European Journal of Cancer 42:779-784.
36. Piret B, Schoonbroodt S, Piette J. 1999. The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 18:2261-2271.
37. Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG, Scott D. 1999. Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer? American Journal of Human Genetics 65:784-794.
38. Scott D. 2004. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenetics and Genome Research 104:365-370.
39. Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA. 1999. Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. International Journal of Radiation Biology 75:1-10.
40. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Borresen-Dale AL, Lonneborg A. 2005. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Research 7:R634-644.
41. Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA. 2005. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochemical and Biophysical Research Communications 326:218-227.
42. Smart V, Curwen GB, Whitehouse CA, Edwards A, Tawn EJ. 2003. Chromosomal radiosensitivity: A study of the chromosomal G(2) assay in human blood lymphocytes indicating significant inter-individual variability. Mutation Research 528:105-110.
43. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT. 2000. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637-2645.
44. Terzoudi GI, Jung T, Hain J, Vrouvas J, Margaritis K, Donta-Bakoyianni C, Makropoulos V, Angelakis P, Pantelias GE. 2000. Increased G2 chromosomal radiosensitivity in cancer patients: The role of cdk1/cyclin-B activity level in the mechanisms involved. International Journal of Radiation Biology 76:607-615.
45. Tibshirani R, Hastie T, Narasimhan B, Chu G. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences USA 99:6567-6572.
46. Vral A, Thierens H, Baeyens A, De Ridder L. 2004. Chromosomal aberrations and in vitro radiosensitivity: Intra-individual versus inter-individual variability. Toxicology Letters 149:345-352.
47. Wasserman J, Petrini B, Wolk G, Vedin I, Glas U, Blomgren H, Ekre HP, Strannegard O. 1991. Cytokine release from mononuclear cells in patients irradiated for breast cancer. Anticancer Research 11:461-464.
48. Wilson CL, Miller CJ. 2005. Simpleaffy: A BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21:3683-3685.
49. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN. 2005. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6:168.